A mechanistic study of ultrasonically-enhanced transdermal drug delivery.
about
Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs.Applicability and safety of dual-frequency ultrasonic treatment for the transdermal delivery of drugs.Developing a Commercial Air Ultrasonic Ceramic Transducer to Transdermal Insulin DeliveryPhysical energy for drug delivery; poration, concentration and activation.Challenges and opportunities in dermal/transdermal delivery.Ultrasound-enhanced ocular delivery of dexamethasone sodium phosphate: an in vivo study.Ultrasound-enhanced delivery of antibiotics and anti-inflammatory drugs into the eye.Overview of therapeutic ultrasound applications and safety considerations.Rapid skin permeabilization by the simultaneous application of dual-frequency, high-intensity ultrasound.Physically facilitating drug-delivery systems.Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trendsA physical method to enhance transdermal delivery of a tissue optical clearing agent: combination of microneedling and sonophoresis.Cardiovascular therapeutic uses of targeted ultrasound contrast agents.Noninvasive ultrasonic glucose sensing with large pigs (approximately 200 pounds) using a lightweight cymbal transducer array and biosensorsPerspectives on transdermal ultrasound mediated drug delivery.The use of ultrasound and micelles in cancer treatment.Ultrasound-mediated DNA transfer for bacteria.Ultrasonic drug delivery--a general review.Serum dexamethasone levels after decadron phonophoresis.Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis.An experimental and theoretical analysis of ultrasound-induced permeabilization of cell membranes.Temperature-dependent electrical and ultrastructural characterizations of porcine skin upon electroporation.Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations.Iontophoresis: a potential emergence of a transdermal drug delivery system.Enhanced sonophoretic delivery of 5-aminolevulinic acid: preliminary human ex vivo permeation data.Ultrasound-mediated transdermal protein delivery.Therapeutic ultrasound: its application in drug delivery.Physical methods to promote drug delivery on mucosal tissues of the oral cavity.Microemulsions as a surrogate carrier for dermal drug delivery.Cortisol concentrations in human skeletal muscle tissue after phonophoresis with 10% hydrocortisone gelTreatment of chest wall tuberculosis with transdermal ultrasound-mediated drug deliveryHealing sound: the use of ultrasound in drug delivery and other therapeutic applications.Application of low-frequency sonophoresis and reduction of antibiotics in the aquatic systems.The application of local hypobaric pressure - A novel means to enhance macromolecule entry into the skin.Sonophoresis: recent advancements and future trends.Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention.Transdermal immunization: biological framework and translational perspectives.Prospects for enhancement of targeted radionuclide therapy of cancer using ultrasound.Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.Ultrasound-mediated ocular delivery of therapeutic agents: a review.
P2860
Q28299531-138B04FE-E751-418C-AED1-7B92DE7FDA2CQ30386266-E0F5ECFD-A808-4F21-9C47-A51C17A443B4Q30408482-9DDDE5F9-569D-4073-B162-5C895C23C272Q30412855-FC8CE971-6DBC-4A90-99A0-DD492BE04715Q30432573-B33F1BBE-92E4-4E15-A9D2-BB67DF7D91BAQ30436895-47DAF299-AD23-4006-84D1-1C49A493750AQ30441010-EAA654E1-9639-43B8-8903-46686321468AQ30447970-19A20C28-61CA-4654-A3B1-AA0C5D3F8242Q30448000-45090A9D-F97C-4C02-B0C0-C19E5EAF8793Q30462003-E9AC81A7-D040-48BE-A2CF-7B4E902B6D2EQ30463832-00732F4E-4CBF-41D1-84C2-227CD356F0F9Q30474449-30D13B13-420D-4FA0-805A-F5F7FA12A67FQ30479697-9A5DC468-A494-4DC1-A209-131215524EB9Q30481712-77DF4406-FEF1-42CA-BFC5-271FBC13BB5EQ30489692-2D0CB682-C61E-49EF-B9E6-2451AE68CC35Q30493664-8545BA13-9817-460D-8DD6-170F093C75E3Q30499511-AA8A9ABE-E84B-479A-A20A-F0C5AB2421BDQ30502960-F0C3B207-7496-4A22-A567-06A6439414D7Q30503403-5D8730FE-6DD7-46D2-B168-0118A84D4672Q30503506-6A65F7AD-C48C-4D30-B08D-0A5FB9C440BBQ30503526-176ADF77-6BDA-4336-80F7-B5052D8041BDQ34179649-344AB943-93F9-4B63-89C8-8D497EEEC149Q34227000-2CE9D0D0-7D12-49B1-9A53-5BC3974F7A7BQ34259364-A856B5CE-C6AD-4259-8761-BA6DF113A106Q34294126-352AAE25-0F59-4ACA-8204-CAB6990A77EEQ34302449-F20F6F12-C99D-438A-83E2-D306DFCEA797Q34540070-EDF6C3D3-C792-45F7-95BF-1A66F811BC1FQ34784578-AFE3690F-CE32-4230-93C4-08BAC0FE1AACQ34882750-54BCB12D-070E-487B-AC8D-C6C6765CBF82Q35038148-3E396F20-0B72-4B0F-8A20-EE93746E4288Q35159597-4E79B0A4-A7B5-424D-AECA-3B59F7909DAFQ36058462-DD218142-735D-4483-8DC0-7A899BC33535Q36376352-653A9E8D-1CC9-420E-9B4B-2338688DECE9Q36761758-C22E1435-B33D-477D-AE68-09D75C1901DEQ37511028-89BD026D-4F91-435C-B01E-EE963F4D9803Q37727325-57EECCE9-8F79-4EDA-B524-7355DF14153BQ38068975-BB0192EA-B7E3-4DAF-A035-73FEA45536F2Q38172067-2D69CFDB-4FCF-44F5-A0D5-5670C7AD52CDQ38195730-1CBE37A8-3CDA-4BFB-AC8D-9249E8E5DCC8Q38867140-C7E0F576-63E3-4136-B17D-846F5A9352CB
P2860
A mechanistic study of ultrasonically-enhanced transdermal drug delivery.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
A mechanistic study of ultrasonically-enhanced transdermal drug delivery.
@en
type
label
A mechanistic study of ultrasonically-enhanced transdermal drug delivery.
@en
prefLabel
A mechanistic study of ultrasonically-enhanced transdermal drug delivery.
@en
P2093
P356
P1476
A mechanistic study of ultrasonically-enhanced transdermal drug delivery.
@en
P2093
D A Edwards
D Blankschtein
S Mitragotri
P304
P356
10.1002/JPS.2600840607
P407
P577
1995-06-01T00:00:00Z